靶向肺泡II型细胞脂代谢蛋白FASN和GPAM可减少肺转移
该研究探讨肺泡II型(AT2)细胞来源脂质对肺转移的作用。空间分析显示乳腺癌肺转移灶刺激邻近AT2细胞增殖并重编程为脂质供体细胞,转移灶分泌组激活AT2细胞中SREBP-1,上调FASN和GPAM等脂质合成基因。在小鼠中,AT2细胞选择性敲除Fasn或系统性靶向FASN和GPAM可显著抑制肺转移生长。
要点
- 乳腺癌肺转移灶可重编程邻近AT2细胞为脂质供体细胞
- 转移灶分泌组通过SREBP-1上调AT2细胞FASN和GPAM表达
- 靶向AT2细胞FASN/GPAM可抑制小鼠肺转移生长且无明显不良反应
核心结论
- 显性肺转移灶可重编程AT2细胞,靶向AT2细胞脂代谢可抑制转移生长。
研究设计与样本
- 研究使用小鼠模型和患者样本进行空间分析,并开展AT2细胞选择性基因敲除及系统性药物靶向实验。
主要发现
- 乳腺癌来源肺转移灶刺激邻近AT2细胞增殖并重编程为脂质供体细胞。
- 转移灶分泌组激活AT2细胞中SREBP-1,增强FASN和GPAM等脂质合成基因表达。
- AT2细胞选择性敲除Fasn或系统性靶向FASN和GPAM显著损害小鼠肺转移生长。
临床怎么用
- 靶向肺驻留AT2细胞的脂代谢(FASN和GPAM)可能成为抑制乳腺癌肺转移的新策略。
局限性
- 研究主要基于小鼠模型,临床转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Cancer cells that seed in the lung require lipids often produced by alveolar type II (AT2) cells. However, whether overt metastases depend on AT2 cell-derived lipids and whether AT2 cells can be targeted to reduce metastasis growth remains unknown. We discovered that breast cancer-derived lung metastases stimulate the proliferation of AT2 cells in their vicinity and reprogram them into lipid feeder cells in mice and patients using spatial analysis. Mechanistically, the metastasis secretome activates the transcription factor sterol regulatory element-binding transcription factor 1 (SREBP-1) in AT2 cells, enhancing the expression of key de novo lipid synthesis genes, including fatty acid synthase (FASN) and glycerol-3-phosphate acyltransferase 1 (GPAM). Deleting Fasn selectively in AT2 cells or targeting FASN and GPAM systemically significantly impairs lung metastasis growth in mice. In summary, we discovered that overt metastases reprogram AT2 cells and that targeting the lipid metabolism of AT2 cells impairs metastasis growth. SIGNIFICANCE: Current therapies in oncology targeting the cancer or immune cell compartment of tumors show limited efficacy against breast cancer-derived metastases. We discovered that decreasing the lipid metabolism of lung resident AT2 cells is sufficient to impair lung metastasis growth in mice without apparent adverse effects.
引用
- Liu XZ, Panina Y, Cai W, et al. Targeting the Lipid Metabolism Proteins FASN and GPAM in Alveolar Type II Cells Decreases Lung Metastasis. Cancer Discov. 2026. PMID: 41778850. doi:10.1158/2159-8290.CD-25-0191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。